Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications


Hebaallah Mamdouh Hashiesh | M.F. Nagoor Meeran | Charu Sharma | Bassem Sadek | Juma Al Kaabi | Shreesh K. Ojha | Hebaallah Mamdouh | M.F. Nagoor | Juma Al | Shreesh K


These effects are mediated via the binding of BCP to CB2R, which activates PGC1-α and promotes the interaction between PPAR-γ and different transcriptional factors, such as PPAR-α leading to increase in the expression of enzymes involved in the oxidation of fatty acids in the liver. Diabet. Diabet. Diabet. Diabet.

Visit Link


Tags: